Ig20Gly Tolerability and Infusion Characteristics in Pediatric and Advanced Age Patients With Primary Immunodeficiency Diseases

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Characteristics of Pediatric Patients Evaluated for Primary Immunodeficiency

Pediatrics
Child HealthPediatricsPerinatology
2012English

Primary Immunodeficiency Diseases.

Annals of Internal Medicine
Internal MedicineMedicine
1984English

Primary Immunodeficiency Diseases

2017English

Intraosseous Infusion in Pediatric Patients

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

T-Cell Subsets Analyzed by Monoclonal Antibodies in Patients With Primary Immunodeficiency Diseases.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1984English

Safety and Tolerability of AZD5363 in Japanese Patients With Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2016English

Expanding TREC and KREC Utility in Primary Immunodeficiency Diseases Diagnosis

Frontiers in Immunology
AllergyImmunology
2020English

Tolerability of Higher Than Current Infusion Rate and Volume of the 20% Subcutaneous Immunoglobulin IgPro20 in Primary Immunodeficiency: An Open-Label Multicenter Study (HiLo)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Clinical and Epidemiological Characteristics of Patients With Suspected Primary Immunodeficiency Disorders Attending Alexandria University Children’s Hospital

International Journal of Contemporary Pediatrics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy